VISION

St. Luke's Medical Center will be an internationally recognized academic medical center by the year 2020.

MISSION

We are committed to deliver state-of-the-art healthcare because at St. Luke’s Medical Center, the needs of our patients come first.

VALUES

• Integrity and Professionalism

  We always do what is professional, ethical and right.

• Patient-Centered Care

  We put the needs of our patients at the core of what we do through outstanding clinical outcomes and great patient experience.

• Innovation

  We always seek opportunities to continuously improve work to maintain the highest standards of patient care and service delivery.

• Passion for Excellence

  We strive to consistently exceed the highest standards of quality in everything we do.

• Synergy

  We always work as a team to ensure the delivery of the best possible healthcare experience to our patients and their families.

• Social Responsibility

  We live up to our commitment in extending our healthcare expertise in social service, community health and environment safety.

•  

COMPANY PROFILE

St. Luke’s Medical Center is recognized as the leading and most respected healthcare institution in the Philippines. Its two facilities in Quezon City and Global City, Taguig are at par with the most advanced hospitals around the world. A testament to St. Luke's world class quality medical service is its accreditation with, and affiliation to, prestigious international organizations.

 

St. Luke’s - Quezon City has the sole distinction of being the first hospital in the country accredited by the JCI, or Joint Commission International: the international arm of the Joint Commission on Accreditation of Healthcare Organizations (JCAHO)—the oldest and most prestigious healthcare accreditation organization in the world—which the facility received in 2003. It is also only the second hospital in Asia to be JCI-accredited. In 2016, it was also the first in the country to be accredited by JCI as an Academic Medical Center Hospital. St. Luke’s - Global City, on the other hand, earned its own JCI hospital accreditation in 2012 after only two years of operation. Both hospitals are also accredited by JCI for the Clinical CareProgram Certification (CCPC) for the Primary Stroke Program.

 

Germany-based accrediting body Temos (Trust, Effective Medicine, and Optimized Services) accredited both hospitals for Excellence in Medical Tourism and Quality in International Patient Care. St. Luke’s - Quezon City and Global City have also been recognized by the Diplomatic Council of Europe, in 2014 as two of only 20 “Best Hospitals Worldwide,” and in 2016 as part of the prestigious group’s list of “Preferred Partner Hospitals”.

 

The passion to continuously improve, redefine, and evolve excellence in medical and patient services has been the cornerstone of SLMC’s mission to deliver state-of-the-art healthcare. This is also guided by key drivers: good clinical outcomes, patient safety, education, training and research, a superior patient experience, and financial viability.

 

St. Luke's Quezon City and Global City hospitals possess a combined total of 1,146 well-appointed rooms to ensure that all patients can be comfortably attended to, without fear of a shortage in accommodations. Each is equipped with the best available equipment depending on patient requirements, even providing bespoke services such as a selective menu, a private butler, and advanced living amenities. St. Luke's believes that comfort and a positive experience are vital in the quest for health and recovery, and its range of patient rooms are designed with precisely these in mind.

 

It is because St. Luke's rooms provide a restorative space perfect for healing that they are a sought-after choice for patients who need hospital care. A testament to this would be the combined average number of in-patient admissions per year for both Quezon City and Global City Hospitals, which is at 60,321 annually. Meanwhile, an average of 2.7 million yearly outpatient consultations indicates that St. Luke's is also the top-of-mind choice even when patients are not required to be admitted.

 

With 12 institutes and various departments and centers serving its patients, St. Luke's practices a multidisciplinary and comprehensive approach to the diagnosis and treatment of specific medical conditions, while significant investments have been made to acquire advanced medical technologies and equipment that provide the most accurate diagnostics possible. In the hands of skilled and committed doctors, these advanced tools help propel St. Luke's and its capabilities to the forefront of healthcare service in the Philippines. A rundown of the institution's most prominent centers and cutting-edge technologies verifies the hospital's position as a pioneer in the country’s health and wellness sphere:

 

St. Luke's Research and Biotechnology arm, based in Quezon City, is a prime mover and catalyst in the advancement of medical science in the Philippines. Its remarkable progress is marked by the wealth of scientific data generated from the development of several molecular diagnostic tests which are then carried over to clinics and hospital wards, thereby elevating the standard of healthcare in the country.

 

St. Luke's also offers Robotic Surgery, which is used to enhance the capabilities of surgeons in operations with limited maneuverable space. This technology has been used in urologic, gynecologic, ENT-HNS, and general surgery cases, and is a highly specialized surgical method that offers patient benefits such as minimal pain, less trauma, a shorter hospital stay, and minimal to no scarring. To date, St. Luke's has already performed close to 1000 Robotic Surgery procedures, and this number is expected to rise considering that it is a precise, painless, minimally-invasive technique. St. Luke's Robotic Surgery arm is also recognized as the fastest growing one of its kind in South East Asia.

 

The Transcatheter Aortic Valve Replacement (TAVR) procedure was first made available in the Philippines at St. Luke's, allowing doctors to treat Aortic Stenosis (AS) without having to resort to open-heart surgery. St. Luke's has already reached the 100 patient milestone for TAVR patients, which places it comfortably in the top three in Southeast Asia for the most number of TAVR procedures performed in the region.

 

In order to provide a safer, faster alternative to medication and the typical ablation procedure for patients who suffer from Atrial Fibrillation (AF), St. Luke's acquired a CryoConsole System—the first of its kind in the Philippines. Operated by trained Cardiac Electrophysiologists, the Arctic Front Advance™ Cardiac Cryoballoon Ablation System enables the minimally invasive practice of catheter ablation for patients. This procedure reduces the recovery time required by normal catheter ablation, allowing patients to return to regular activities in just two weeks.

 

St. Luke's also addresses the limited number of organ donations in the Philippines with the establishment of its own Center for Organ Transplantation. The Center performs both living and deceased organ transplantation procedures with survival rates at par with international outcomes—reported by the best centers around the world—and is promptly capable of performing living-donor liver transplants. St. Luke's is also the first hospital in the Philippines to be accredited by PhilHealth for the “Z” Package, making organ transplantation at St. Luke's more affordable and accessible to more Filipinos.

 

To be able to treat peritoneal carcinomatosis more effectively, St. Luke's has made Hyperthermic Intraperitoneal Chemotherapy, or HIPEC, available to those afflicted with this rare type of cancer. HIPEC is the gold standard when it comes to this type of treatment, delivering the highly concentrated, heated chemotherapy to the affected area with more accuracy.

 

St. Luke's Center for Advanced Reproductive Medicine and Infertility (CARMI) is the only hospital-based In-Vitro Fertilization (IVF) unit in the Philippines.

 

St. Luke's - Global City Facility is home to the country’s first Center for Advanced Gastrointestinal Endoscopy, under its Institute of Digestive and Liver diseases. The diagnostic and therapeutic center addresses upper and lower gastrointestinal diseases using state-of-the-art technology from Japan. Among the available procedures at the center are Endoscopic Mucosal Resection (EMR) and Endoscopic Submucosal Dissection (ESD), which do not require open surgery.

 

St. Luke's Brain Attack Team (BAT), the first of its kind to be globally-recognized and accredited by the JCI, ensures the rapid and correct treatment of stroke. The BAT is composed of neurology and neurosurgery stroke consultants, stroke fellows, stroke nurses, emergency department doctors, radiology consultants, and endovascular specialists.

 

ST Elevation Myocardial Infarction, or STEMI, demands rapid medical response. It is with this in mind that St. Luke's created the STEMI Team, specifically to address the needs of STEMI patients. Emergency physicians and nurses, coronary care unit nurses, Cathlab staff, and committed interventional cardiologists who adhere to international standards of treatment and response time comprise the team.

 

The institution's Molecular Pathology arm, on the other hand, specializes in examining diseases and conditions from the root. To properly classify conditions, Molecular Pathology examines them through the molecular structure of the patient, providing a more accurate interpretation for a more personalized treatment. This multidisciplinary approach is commonly used in the diagnosis of cancer and other infectious diseases.

 

St. Luke's is also proud to possess some of the most advanced technology in the Philippines. Among St. Luke's cutting-edge tools are an Advanced TrueBeam system which offers a range of capabilities for cancer care, research, and treatment; Thulium Laser for safe and blood-less enucleation; a Philips Azurion 7 paired with a Volcano CORE Mobile system, which is an advanced image-guided therapy solution, now part of St. Luke's Cathlab; and a high-resolution, personalized diagnostic procedure–the Gallium-68 (Ga-68) PET imaging.

 

Aside from its international accreditations and affiliations, its well-equipped accommodations, and its advanced medical systems and technologies, St. Luke's also inspires confidence in patients as a healthcare institution that employs doctors and associates who are willing to learn and practice medical and healthcare services in a dynamic environment. This is evident in the hospital’s 23 accredited residency programs and 56 accredited fellowship training programs­—all of which are geared towards learning, and sharing in the hospital, while staying unified under the umbrella of delivering the best in patient care and service.

 

Future competent and compassionate medical professionals are educated and trained at the St. Luke’s Medical Center College of Medicine-William H. Quasha Memorial (SLMCCM-WHQM). The medical school grants full scholarships to the best and brightest graduates of leading colleges and universities. It also offers international clinical observerships and the MS Molecular Medicine Program.

 

 

 

In both Global City and Quezon City hospitals, Patient Experience Officers are always on hand to assist patients and their families with medical and personal concerns.

 

Up on the horizon for St. Luke's is the upcoming completion of St. Luke’s Medical Center–Davao City between 2020 and 2021. Located at Azuela Cove in Lanang, a prime waterside location, the facility promises to continue the institution's commitment to top-notch medical services and patient care. Aside from a flagship St. Luke’s Medical Center hospital, the 25-hectare, master-planned mixed use community will also feature low- to mid-rise residential towers, commercial lots, office spaces, an events venue, and a waterside cove with retail and lifestyle options.

 

St. Luke’s Medical Center will relentlessly pursue its vision and mission for many years to come, and will continue to be the country’s premier medical institution and hospital of choice for local residents and medical travellers.